NCCN 2021
National Comprehensive Cancer Network Annual Cconference
March 18-20, 2021 | Virtual
Improving response in B-cell lymphomas with chimeric antigen receptor T-cell therapy
New perspectives on the management of unfit patients with acute myeloid leukemiaNew perspectives on the management of unfit patients with acute myeloid leukemia
Contemporary management of gastrointestinal stromal tumors
More radiotracers approved for PSMA PET/CT scan in the metastatic castration-resistant prostate cancer diagnosis
Biomarkers for advanced non-small cell lung carcinoma: quo vadis?
Updated NCCN guidelines on the management of HER2-positive breast cancer
Updated NCCN guidelines on the management of multiple myeloma